MVM Life Science Partners: €20M-€100M checks, Seed to Growth
- Check size
- €20M – €100M
Investment focus
Sectors
Geographic focus
Investment thesis
Global healthcare VC. $700M+ across 4 funds. Invests in biopharma, medtech, and digital health from seed to late stage. Aggregate $20-100M per company over holding period.
How to Pitch MVM Life Science Partners
No stated policy
MVM Life Science Partners hasn't published an outreach policy. A short, specific cold email is the safest default.
Who to contact
Addison Van Emon
Arantza Rodriguez
Portfolio highlights
GT Medical Technologies
GammaTile
Neurent Medical
Proverum
Nalu Medical
Avanzanite
Partners
Auto-detected from MVM Life Science Partners's website.
Similar investors
- UCL Technology FundUnited Kingdom · AI, Biotech, Healthtech
- Crista Galli VenturesUnited Kingdom · AI, Biotech, Healthtech
- Outsized VenturesUnited Kingdom · AI, Biotech, Healthtech
- KHP VenturesUnited Kingdom · AI, Biotech, Healthtech
- Imperial College Enterprise FundUnited Kingdom · AI, Biotech, Healthtech
Focus and check size from the firm's website. Website reachable as of Nov 2026.
Ready to reach MVM Life Science Partners?
Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.
Contact
mvm.com
Reach MVM Life Science Partners through the links above. Pitchkit is not affiliated with the firm and does not forward pitches.